Only in the last few years has non-
alcoholic steatohepatitis been recognized as an important and relatively common
liver disease. To date, the therapeutic options are limited,
vitamin E and
metformin have been proposed for the treatment of this condition, although their mechanisms are not completely clarified as yet. The aim of this study was to investigate the anti-inflammatory and anti-oxidative mechanisms of these drugs in an experimental model of non-
alcoholic steatohepatitis in the young rat. Male rats, just after weaning, were divided into four groups: a control group that received a standard diet; a high fat diet group; two high fat diet fed groups treated with
vitamin E or
metformin, respectively. After 4 weeks, we evaluated in the liver the modification of lipid peroxidation, assessed by
malondialdehyde,
TNF-alpha levels, S-nitrosylated
protein, inducible
nitric oxide sinthase (iNOS), and
peroxisome proliferators-activated receptors (
PPAR) expression and
metalloproteinase activity. High fat diet increased
malondialdehyde, nitrotyrosilated
proteins, and
TNF-alpha tissue content. Moreover, a decrease of
PPAR-alpha and an increase of
PPAR-gamma expression were observed. An increase of
metalloproteinase activity was also shown. Among drug treatments,
metformin reduced
body weight gain and fat mass,
metalloproteinase activity, and
TNF-alpha tissue content, while it restored
PPAR-alpha expression and downregulated
PPAR-gamma expression.
Vitamin E reduced the oxidative damage,
protein nitrotyrosilation, and tissue
TNF-alpha levels. Moreover a decrease of
PPAR-gamma expression was also shown. These findings confirm the efficacy of both drugs as therapeutic tools in preventing the early onset of liver damage and
non-alcoholic fatty liver disease progression.